111 related articles for article (PubMed ID: 3022044)
1. Antitumor, antiviral and natural killer-inducing activities of human recombinant interferon-alpha in the guinea pig.
Kataoka T; Ishitsuka H; Tokunaga T
Jpn J Med Sci Biol; 1986 Apr; 39(2):97-103. PubMed ID: 3022044
[TBL] [Abstract][Full Text] [Related]
2. [Effect of natural and recombinant interferons on the development of an antiviral state and on the activity of natural killers].
Kuznetsov VP; Avdeev GI; Viadro MM; Leĭkin IuD; Frolova IS
Dokl Akad Nauk SSSR; 1985; 284(6):1514-6. PubMed ID: 3002740
[No Abstract] [Full Text] [Related]
3. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines.
Overall JC; Yeh TJ; Kern ER
J Interferon Res; 1984; 4(4):529-33. PubMed ID: 6094683
[TBL] [Abstract][Full Text] [Related]
4. A new assay system for guinea pig interferon biological activity.
Yamamoto T; Jeevan A; Ohishi K; Nojima Y; Umemori K; Yamamoto S; McMurray DN
J Interferon Cytokine Res; 2002 Jul; 22(7):793-7. PubMed ID: 12184917
[TBL] [Abstract][Full Text] [Related]
5. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
6. Virus-specific effects of recombinant porcine interferon-gamma and the induction of Mx proteins in pig cells.
Horisberger MA
J Interferon Res; 1992 Dec; 12(6):439-44. PubMed ID: 1337754
[TBL] [Abstract][Full Text] [Related]
7. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat.
Katafuchi T; Take S; Hori T
J Physiol; 1993 Jun; 465():343-57. PubMed ID: 8229839
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.
Kawamoto S; Oritani K; Asada H; Takahashi I; Ishikawa J; Yoshida H; Yamada M; Ishida N; Ujiie H; Masaie H; Tomiyama Y; Matsuzawa Y
J Virol; 2003 Sep; 77(17):9622-31. PubMed ID: 12915574
[TBL] [Abstract][Full Text] [Related]
9. Biological activities of synthetic peptides of the sequence of human interferon-alpha.
Eichmann E; Majarov VA; Kozhich AT; Noll F; Zav'yalov VP
Immunol Lett; 1990 Jul; 24(4):233-6. PubMed ID: 2167875
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of virus inhibition by consensus interferon YM643.
Yasuda S; Huffman JH; Smee DF; Sidwell RW; Miyata K
Antivir Chem Chemother; 2000 Sep; 11(5):337-41. PubMed ID: 11142632
[TBL] [Abstract][Full Text] [Related]
11. Production, purification and biological properties of an Escherichia coli-derived recombinant porcine alpha interferon.
Lefèvre F; L'Haridon R; Borras-Cuesta F; La Bonnardière C
J Gen Virol; 1990 May; 71 ( Pt 5)():1057-63. PubMed ID: 1693161
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.
Shinozaki K; Ebert O; Suriawinata A; Thung SN; Woo SL
J Virol; 2005 Nov; 79(21):13705-13. PubMed ID: 16227290
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans.
Hawkins MJ; Borden EC; Merritt JA; Edwards BS; Ball LA; Grossbard E; Simon KJ
J Clin Oncol; 1984 Mar; 2(3):221-6. PubMed ID: 6321691
[TBL] [Abstract][Full Text] [Related]
14. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
Koyama AH; Arakawa T; Adachi A
Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
[TBL] [Abstract][Full Text] [Related]
15. Assays for antiviral activity.
Meager A
Methods Mol Biol; 2004; 249():121-34. PubMed ID: 14573896
[No Abstract] [Full Text] [Related]
16. A recombinant human interferon-alpha B/D hybrid with a broad host-range.
Horisberger MA; de Staritzky K
J Gen Virol; 1987 Mar; 68 ( Pt 3)():945-8. PubMed ID: 3029315
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro.
Peek SF; Bonds MD; Gangemi DG; Thomas CB; Schultz RD
Am J Vet Res; 2004 Jun; 65(6):871-4. PubMed ID: 15198231
[TBL] [Abstract][Full Text] [Related]
18. Differences in murine gut-associated lymphoid tissues in generating broadly nonspecific cytotoxic cells in response to interferon alpha A/D and interleukin 2.
Chikkala NF; Gautam SC
Cell Immunol; 1991 Jul; 135(2):418-30. PubMed ID: 2036676
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic activities of human interferons are mediated by multiple response pathways.
Forti RL; Mitchell WM; Hubbard WC; Workman RJ; Forbes JT
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):170-4. PubMed ID: 6320163
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
